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tration was abnormally high at 152 mm. A genetic screening
for 70 common alleles of cystic fibrosis was negative.
The infant’s electrolytes stabilized with sodium chloride sup-
plementation, and he proceeded to gain weight normally. Addi-
tional testing revealed that the nasal transepithelial voltage was
approximately zero mV and showed no amiloride sensitivity.
(Normal baseline values for patients this age are more negative
than 220 mV.) The response to beta-adrenergic agonists was
normal. The patient did not respond to exogenous mineralocor-
ticoid therapy. The urinary sodium excretion was 41 mEq/liter
and a simultaneous urinary potassium level was 1 mEq/liter.
Oxygen saturation throughout the entire hospital stay was
within normal limits. The hyperbilirubinemia resolved with
phototherapy. Evaluation of the renin-angiotensin axis in the
parents showed completely normal values in the father and
marginally elevated plasma aldosterone values in the mother.CASE PRESENTATIONS
Patient 2. A 16-year-old female was referred for hyperten-Patient 1. A five-day-old Hispanic boy was the result of
sion, hypokalemia, and metabolic alkalosis. Two siblings hadan uncomplicated pregnancy. The vaginal delivery and Apgar
similar findings. The patient’s blood pressure averaged 180/scores were normal. Neonatal jaundice secondary to ABO in-
120 mm Hg. The serum potassium was 2.6 mEq/liter; bicarbon-compatibility was treated with phototherapy. The baby had no
ate, 30 mEq/liter; and arterial blood pH, 7.45. Despite thefamily history of congenital disorders.
hypokalemia, she excreted 80 mEq of potassium per day. Eval-Physical examination disclosed a weight of 2870 g and was
uation showed a barely detectable aldosterone secretion rateunremarkable except for jaundice. Neurologic development
but normal excretion of other adrenal corticosteroids. Uponwas appropriate for age, and there was no sexual ambiguity.
dietary salt restriction, she was able to eliminate sodium fromLaboratory examination revealed a serum sodium of 128 mEq/
her urine normally.liter; potassium, 7.7 mEq/liter; chloride, 87 mEq/liter; and bi-
Twenty-nine years later, she developed end-stage renal dis-carbonate, 18 mEq/liter. The BUN was 24 mg/dl and the serum
ease and was begun on dialysis. Shortly thereafter she under-creatinine 0.4 mg/dl. The white blood cell count was 23,900/
went a cadaveric kidney transplant and currently has excellentmm3; the hematocrit, 56%; and the total bilirubin, 20.6 mg/dl.
renal function with only mild hypertension (140/90 mm Hg).Direct bilirubin was 1.3 mg/dl. Blood gas evaluation showed
She currently has normal serum potassium and acid-base values.pH, 7.51; PCO2, 29 mm Hg; and PO2, 48 mm Hg. He was
transferred to the University of Iowa Hospitals.
The baby was treated with 10% glucose and normal saline, “Nature is nowhere accustomed more openly to display her secret
insulin infusion, oral sodium polystyrene sulfonate, and 9 alpha mysteries than in cases where she shows traces of her workings apart
fluorohydrocortisone, 0.1 mg orally daily. Subsequent labora-
from the beaten path.”tory examination showed a plasma aldosterone of 1218 ng/dl
William Harvey, 1657(normal, 5 to 90 ng/dl), and a plasma renin activity of 350 ng/
ml/hr (normal, 0.5 to 3.0 ng/ml/hr). The sweat chloride concen-
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Table 1. Characteristics of the three types of whether this group of disorders should be included in
pseudohypoaldosteronism
the designation pseudohypaldosteronism.
Salt Type-I PHA includes a group of patients represented
GFR BP wasting [HCO23 ] [K1] Renin Aldosterone by today’s first case. They are characterized by normal
Type I ↓,N ↓ Yes ↓ ↑ ↑ ↑ renal function, a tendency to waste salt, hypotension,
Type II N ↑ No ↓,N ↑ ↓↓ ↓,N
hyperkalemia, metabolic acidosis, and high circulatingType III ↓↓ ↓ Yes ↓ ↑ ↑ ↑
renin and aldosterone levels. As exemplified by the index
case, these patients tend to be identified very early in
life and have life-threatening hyperkalemia as their chief
therapeutic challenge. We now understand the majorknown to all nephrologists, is on the cortical collecting
duct (CCD). As illustrated in Figure 1, aldosterone binds molecular problems that lead to this syndrome.
There are at least two genetic types of type-I PHA:to the mineralocorticoid receptor located in the cell cyto-
plasm, which then becomes activated and translocates to autosomal-dominant and autosomal-recessive. The au-
tosomal-dominant form (or perhaps sporadic, as in to-the nucleus. In the nucleus a variety of poorly understood
transcription processes become up- or downregulated; day’s first case) tends to have a relatively mild phenotype
that can be readily controlled by high dietary salt intakethese changes subsequently increase the permeability of
the apical membrane to sodium by increasing the activity and careful attention to potassium balance. Children
with this form of PHA tend to outgrow the syndromeof the epithelial sodium channel (ENaC). The increase
in sodium permeability raises the rate of sodium entry and require little or no management after emerging from
the first few years of life.across the apical (luminal) membrane. Concomitantly
there is an increase in the rate of extrusion of sodium A large fraction of patients with autosomal-dominant
and sporadic type-1 PHA appear to have abnormalitiesacross the basolateral (anti-luminal) membrane by the
Na1/K1 pump. The resulting increase in potassium entry, in the mineralocorticoid receptor gene. Geller et al
showed genetic abnormalities in five kindreds that woulda direct consequence of the increase in sodium extrusion,
raises the rate of potassium extrusion across the apical be predicted to produce major abnormalities in the min-
eralocorticoid receptor protein [3]. These abnormalitiespotassium channel. Most cells have a potassium ion chan-
nel located on the basolateral membrane; this channel include frame-shift mutations, abnormal splicing, and
premature stop codons. These discoveries point to theallows recycling of potassium and produces no net trans-
fer across the epithelium. The CCD, by having a rela- critically important role that the mineralocorticoid re-
ceptor plays in sodium, potassium, and acid-base balancetively low basolateral potassium conductance and a very
high apical membrane potassium conductance, is ideal in early life. These cases also underscore the fact that
the epithelial sodium channel can be dysfunctional as afor secreting large amounts of potassium into the urine
when sodium absorption is substantial. Aldosterone also result of abnormalities in gene products responsible for
its regulation in addition to abnormalities intrinsic to theincreases the activity of the apical potassium channel as
well as the basolateral membrane Na1/K1 pump [1]. gene itself. I will return to this concept later.
The discovery that defects in only one copy of thePseudohypoaldosteronism represents a group of disor-
ders that are commonly classified into three types (Table mineralocorticoid receptor can produce severe imbal-
ance in potassium metabolism in infants came as some-1). All three are characterized by hyperkalemia and met-
abolic acidosis. These disorders thus are considered in what of a surprise. The reason why a single abnormal
copy (expressed with one normal copy) of the mineralo-the general category of type-IV renal tubular acidosis. I
plan to focus my discussion on type-I PHA but first will corticoid receptor produces disease is not clear. The situ-
ation contrasts starkly with the recently published resultsdiscuss briefly types II and III. Type-III PHA results
from a group of acquired disorders that injure the collect- from genetically altered mice that lack the mineralocorti-
coid receptor [4]. In these studies, heterozygous miceing duct, such as medullary cystic diseases or obstructive
uropathy. An important hallmark of type-III PHA is a had a normal phenotype, at least with respect to serum
potassium levels. The heterozygous pups achieved a nor-reduced filtration rate.
Type-II PHA is a controversial designation. As Table mal serum potassium at the expense of a moderately
elevated plasma renin activity and serum aldosterone1 shows, the patients manifesting this disorder do not
invariably have elevated plasma aldosterone and plasma concentration. Thus the reason that human beings with
similar genetic defects appear to have a more difficultrenin levels as one would expect in patients with a “true”
pseudohypoaldosteronism. Perhaps the best described neonatal course remains an enigma.
The other form of type-I PHA is the autosomal-reces-phenotype is Gordon’s syndrome [2]. The molecular de-
fect is not known. Hypertension and a tendency to low sive variety. Chang et al described five kindreds, all in-
volving consanguinity, with major genetic differences inplasma renin and aldosterone levels characterize this
group of patients. Thus, there is reason to question sequences for one of the genes encoding the epithelial
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sodium channel (ENaC) [5]. These kindreds, whose af- stantially different functions [17]. The fact that the rela-
tive amount of messenger RNA for each of the subunitsfected members all have homozygous defects, exhibit
severe phenotypes of salt-wasting, hyperkalemia, and can vary widely in various sites, such as lung, kidney,
colon, urinary bladder, and mechanoreceptors [18–21],metabolic acidosis.
raises the possibility that different stoichiometries can
Molecular nature of ENaC impart different functional consequences.
The discovery and cloning of ENaC [6–8] opened a
The ENaC/DEG superfamilynew chapter in our understanding of electrolyte homeo-
stasis and blood pressure control. For years it has been These ENaC subunits are part of a large family of
molecules that can form ion channels and that are ex-known that one of the major targets for aldosterone’s
action was the apical membrane sodium channel of the pressed in a wide variety of organisms from the primitive
nematode C. elegans to Homo sapiens. Figure 3 showsrenal collecting duct. The technique of expressing mRNA
in the Xenopus oocyte has permitted the cloning of several a portion of the known “family tree.” With the exception
of the ENaC molecules, the function of these proteinsmembrane transport proteins, including the Na1/Cl1 co-
transporter, the Na1/K1/2Cl2 cotransporter, the Na1/ is poorly understood. Those in C. elegans might be mech-
anosensors, because mutations in these proteins causeglucose cotransporter, potassium ion channels, and many
others. The identification of ENaC, however, was com- the nematodes to fail to respond to touch and to develop
degenerative changes in the neurons involved in touchplicated by the fact that it was comprised of three sepa-
rate gene products, all of which were required for its full [22]. Family members from Drosophila might have a
similar function [23]. The function of the acid-sensingexpression. Fortunately, expression of a single subunit,
the a subunit, provided enough channel activity to permit branch of the family remains unclear, although some
researchers have speculated that this branch is involvedits cloning and molecular identification [6]. Shortly there-
after, the b and g subunits of ENaC were identified [7]. in taste and integrated neural functions [22, 24]. Perhaps
individual members of the ENaC family are used forThe molecular organization of a representative sub-
unit, depicted in Figure 2A, is similar for all three sub- mechanosensation and taste in mammals [20, 21, 25] in
addition to their role in forming the classic epithelialunits [9–11]. Each subunit of ENaC has two membrane-
spanning regions with the amino terminus and the carboxy sodium channel.
Researchers generally agree that each member of thisterminus inside the cell. In addition, a large extracellular
loop between the membrane-spanning domains contains family can function as an ion channel. This conclusion
derives from four lines of reasoning. First, the topologyglycosylation sites and cysteine-rich regions. The extra-
cellular regions of these subunits are quite large—much for each of the family members appears to be similar,
and classic ENaC is certainly an ion channel. Second,larger than is the case for other ion channels. The signifi-
cance of such a large extracellular domain is not clear, mutations in analogous channels in C. elegans produce
cell swelling, as if a sodium channel were inappropriatelybut there is speculation that specific regions can interact
with substances in the extracellular environment and activated [26]. Third, certain point mutations introduced
into apparently non-conducting family members can in-modify the function of ENaC. A region of the extracellu-
lar loop near the second membrane-spanning domain duce amiloride-sensitive ion channel activity [27]. Fi-
nally, the most distant family member, the FMRFamide-appears to act as a selectivity filter and might contain a
binding site for amiloride [12]. activated channel from the snail (FaNaCh), can be acti-
vated by an external peptide ligand [28], and the entireThe three subunits come together to form a channel
in ways that are not completely understood. Figure 2B group of acid-sensing channels can be activated by vary-
ing degrees of extracellular acidification. Taken together,is an oversimplified schematic diagram of how each of
the three subunits might interact to form a channel. It these facts suggest that this family of proteins can act as
ion channels under the appropriate circumstances. In atis reasonably clear from the available data that the mem-
brane-spanning domains contribute in some fashion to least some cases, this ion channel capability can transmit
physical information (pH, stretch) from the outside ofthe pore-forming region of the molecule. The stoichiom-
etry of the complex is almost certainly not 1a:1b:1g sub- the cell to the inside.
unit. The actual stoichiometry is unclear, but two views
Mutations in ENaC causing PHAprevail. One view would have the stoichiometry fixed at
four subunits (2a:1b:1g) or perhaps a multiple thereof All the mutations in ENaC that have been identified
in patients with PHA are recessive (Fig. 4, Table 2).[13, 14]. Another view would have the stoichiometry
fixed at 3a:3b:3g subunits [15, 16]. Whether the subunits Most of the mutations produce severe physical disruption
of the affected subunit. The known truncations andalways assemble with the same stoichiometry is also open
to question. Good evidence indicates that they can as- frameshifts cause loss of large sections of the molecule,
including one or both membrane-spanning domains. Itsemble with different stoichiometries to perform sub-
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is not surprising that such major perturbations produce produced striking reductions in the magnitude of the
sodium transport [30]. (Interestingly, six mutations pro-a severely dysfunctional channel in the homozygous state.
In the heterozygous state, these disruptions do not cause duced a significant increase in the magnitude of the so-
dium transport.) In each of the mutations that produceddetectable clinical disease. Thus, in contrast to the defect
in the mineralocorticoid receptor, in which heterozygos- a decrease in the sodium current, a similar reduction
occurred in the amount of sodium channel protein pres-ity can produce disease in the neonate, having one nor-
mal copy of the three ENaC subunits is sufficient to ent on the surface of the oocyte. These studies suggest
that the cysteine residues in the extracellular domainsmaintain nearly normal potassium homeostasis. It is im-
portant to note that disruptions in any one of the three are necessary for delivering an intact sodium channel to
the surface of the cell. The precise mechanisms involvedsubunits produces the PHA phenotype. This clinical ob-
servation underscores the importance of each of the in this process are not clear. The currently available
experimental data offer little evidence for intersubunitthree subunits to the overall functioning of the channel.
Not all the mutations known to produce PHA are disulfide bonding. Rather, intrasubunit disulfide bonding
probably imparts the specific conformations necessaryframeshifts or truncations. Two of them produce a single
amino acid change. Such mutations often can lend con- for adequate delivery to the cell surface [30].
siderable insight into regions of the molecule that are
Experimental models of PHAimportant for its function. A mutation in the b subunit
where the glycine at position 37 is mutated to a serine After the a-ENaC gene was cloned, a logical experi-
ment was to determine the consequences of eliminating(G37S) provides some potentially important lessons.
This region is located on the intracellular side of the first this gene product in an intact animal. Most investigators
in the field expected that animals lacking this subunitmembrane-spanning domain. This glycine is conserved
in each member of the family except the acid-sensing would have hyperkalemia and a salt-losing tendency as
the prominent phenotype. It was not clear whether otherclan and the FaNaCh loner. Reproducing this mutation
in the oocyte expression system creates an ion channel important phenotypes existed nor whether this gene
played a role in normal development.in which the ability to transport sodium is significantly
impaired [29]. It is interesting that when imposed on the The results of disrupting the a-ENaC gene in mice
(that is, the knockout mouse) were surprising. The miceb or the g subunit, the mutation produces an approxi-
mate 50% reduction in the ability to transport sodium died within 36 hours of being born [31]. However, they
died of respiratory distress and pulmonary edema becausein the oocyte expression system. In contrast, when placed
in the a subunit, this mutation reduces the capacity for they were unable to clear fluid from the lungs after birth.
It is important to note that organogenesis was normalsodium transport by about 80%. The reason that this
mutation produces a more severe dysfunction of the a and no fetal wastage was seen; the percent of 2/2 mice
born was similar to that predicted (25%). Thus, thesubunit is not clear.
The mechanism whereby the G37S mutation produces a-ENaC gene product was not necessary for normal or-
gan development but was critical for making a transitiona dysfunctional channel has been investigated by
Gru¨nder et al [29]. One can postulate two basic mecha- from fetal to neonatal life. The importance of a-ENaC
in pulmonary function was beginning to be realized bynisms for defective channel function: (1) an inability of
the cellular machinery to deliver the channel protein to a number of investigators, as several groups had noted
substantial amounts of a-ENaC mRNA in the lung. Itthe cell surface, that is, defective protein trafficking, and
(2) gating of the channel, that is, the ability of the channel is now clear that the expression of this gene product in
the lung is greatly increased in the two to three daysto open and/or close properly. It appears that the G37S
mutation does not impair the protein’s ability to reach immediately prior to birth [19, 32, 33].
These experiments demonstrate important differencesthe surface of the Xenopus oocyte. Rather, it is likely
that this mutation somehow impairs the normal ability between the function of a-ENaC in mice and humans.
Human beings with a completely disrupted a-ENaC geneof ENaC to open. The reason for the defective gating is
not yet known. product have survived into adulthood, albeit with hyper-
kalemia and salt wasting [5]. The explanation for thisA second instructive missense mutation causing PHA
was recently reported. All ENaC family members have difference is not entirely clear, but it seems most likely
that humans have a redundancy that allows for partialtwo regions in the extracellular domain that are rich in
cysteine residues. Sixteen of these cysteine residues are replacement of the a-ENaC function in the lung. This
redundancy need not be robust. Even a small amountconserved among the family members, so the possibility
exists that these residues are critical for the structure or of a-ENaC is capable of rescuing mice that completely
lack this protein [34].function of these proteins. Firsov and coworkers under-
took a systematic mutational study of these residues and Mice with a completely disrupted b- and g-ENaC gene
product have now been constructed [35, 36]. They sharediscovered that four residues, when mutated to serine,
Fig. 1. Schematic of the action of aldosterone on the principal cell of
the cortical collecting duct. The major action is to increase the perme-
ability of the Na1 channel on the apical membrane; this channel is
inhibited by amiloride and triamterene. MR, mineralcorticoid receptor.
Fig. 3. The members of the ENaC/DEG family.
certain features with the a-ENaC knockout mice (Table
3). They have normal organ development, no fetal wast-
age, and all mice die within the first two to three days of
life. The difference between the b- and g-ENaC knockout
mice and the a-ENaC knockout mice is in the mode of
death. The b- and g-ENaC knockout mice die of severe
hyperkalemia and do not exhibit signs of respiratory dis-
tress within the first two days of life [35, 36]. Thus, the
ENaC gene complex is not required for organ develop-
ment but is essential for the transition to extrauterine life.
Why is there a phenotypic difference (in mice) be-
tween disruption of the a-ENaC gene and the b- and
b
Fig. 2. (A) Diagram of a single subunit of ENaC. The general features,
two membrane-spanning domains, a large extracellular loop, and intra-
cellular amino- and carboxy-termini, are typical of all members of this
family. (B) Schematic drawing indicating arrangement of a-, b-, and
g-ENaC into one Na1 channel. The actual channel complex consists of
more than the number of subunits shown here.
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Fig. 4. Mutations in ENaC subunits causing pseudohypoaldosteronism.
Triangles indicate premature stop codons or nonsense mutations. Dots
indicate missense mutations causing one amino acid substitution. Fur-
ther details on these mutations are shown in Table 2.
Fig. 5. Mutations in ENaC subunits causing Liddle’s syndrome. Short
lines represent premature stop codons or nonsense mutations. Dots
indicate missense mutations causing one amino acid substitution. Fur-
ther details on these mutations are shown in Table 4.
Fig. 6. (A) Interaction of one ENaC subunit with Nedd4, a protein
g-ENaC genes? The answer to this question is not clear. involved in regulating surface expression. (B) Endoctyosis of a single
ENaC subunit as a result of its interaction with Nedd4 and its ubiquitina-One possible explanation why the b- and the g-ENaC
tion (represented by a circle).knockout mice do not have respiratory distress might be
the way the channel complex is formed in the lung. We
know that there is relatively more a-ENaC mRNA in
the lung than in other organs [19, 37]. We also know in the lung increases greatly in the two to three days
that a-ENaC, when expressed alone in oocytes, can form before birth (relative to b- and g-ENaC), its expression
a sodium channel, albeit with a much lower activity than in the kidney and colon is more gradual and quantita-
when all three subunits are expressed together [7, 38]. tively less [18, 19]. Thus, a relatively large amount of
The a/g-ENaC and a/b-ENaC channels are more active a-ENaC in the lung might be able to prevent a pulmonary
than are the a-ENaC channels, but b/g-ENaC channels phenotype in the b- and g-ENaC knockout mice. How-
are non-functional. A unifying hypothesis regarding the ever, the more modest amounts of a-ENaC in kidney
phenotypic difference between these knockout mice might not be sufficient to prevent the lethal hyperkalemia.
could be constructed as follows. A normal level of Why can humans survive disruption of any one of the
a-ENaC expression in the lung can combine with b- or three ENaC genes and mice not? The pundits will quickly
g-ENaC to form channel activity sufficient to reabsorb point out that mice are different from human beings.
lung fluid after birth. However, these a/g-ENaC or a/b- However, a more considered view should include the
ENaC channels (in the kidney) are insufficient to provide possibility that humans might have a redundant mole-
adequate potassium homeostasis. cule—as yet undiscovered or unrecognized—that can
This hypothesis might not be complete. Recent work function as a partial surrogate for the defective ENaC
from our laboratory has demonstrated that the develop- subunit. The amount of the putative surrogate protein,
mental expression of the three ENaC subunits is not the or the degree to which it can fully substitute, need not
be great. A recently published set of experiments demon-same in each organ. Whereas the expression of a-ENaC
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Table 2. Mutations in ENaC subunits causing pseudohypoaldosteronism
In vitro
Subunit Mutation expression Inheritance Comments Reference
a-ENaC I68fs Recessive [5]
a-ENaC R508X Recessive [5]
a-ENaC C133Y ,10% control Recessive Temperature sensitive [30]
b-ENaC G37S 40% control Recessive [5]
g-ENaC KYS106–108N; 134X Recessive [86]
Abbreviations are: I, isoleucine; R, arginine; C, cysteine; G, glycine; K, lysine; Y, tyrosine; S, serine; N, asparagine; X, stop codon; fs, frameshift mutation.
strated that mice engineered to have very low levels of that defects in ENaC or in its regulation caused the
Liddle’s phenotype.b-ENaC survive with normal pulmonary function and
electrolytes [39]. The PHA phenotype was detectable
Pathophysiology of Liddle’s syndromeonly after dietary salt restriction.
Shimkets et al discovered that the genetic defect inThe general lessons that we can take away from the
the original Liddle’s syndrome kindred was a mutationcombination of human and mouse genetic disruption of
in b-ENaC [43]. This discovery has stimulated an intenseENaC are that all three ENaC genes are necessary for
interest in understanding the precise molecular eventsnormal existence, and that humans and mice do not have
linking this mutation to enhanced sodium absorptionto have a fully expressed complement of subunits to
by the CCD. The original kindred has a mutation thatsustain a relatively normal existence. As is the case for
produces a truncation in b-ENaC such that the entiremany other gene products, a small fraction of the normal
intracellular carboxy terminus is not synthesized. It iscomplement often can ensure a relatively normal exis-
important for us to remember that affected family mem-tence. However, such defects could predispose to hyper-
bers have one normal gene copy and one abnormal genekalemia and metabolic acidosis, particularly under cir-
copy, that is, they are heterozygous and the disorder iscumstances of dietary salt restriction.
autosomal-dominant. This mutation fits the classic de-
scription of a “gain-of-function mutation.” The loss ofLiddle’s syndrome
the C-terminus therefore must result in the loss of aToday’s second patient was originally reported by
regulatory function that decreases the permeability of
Grant Liddle in 1963 [40] and revisited in 1994 [41].
the ENaC complex. This loss of a negative regulatory
She displays the features of the syndrome subsequently function thus produces a molecule with greater function
named after the investigator who originally described it. (that is, higher sodium permeability). Figure 5 and Table
Liddle’s original description is a remarkably complete 4 demonstrate the known mutations in ENaC that
and lucid evaluation of a metabolic problem that defied produce Liddle’s syndrome. At least six kindreds have
molecular explanation for more than 30 years. One of the truncations of the C-terminus of b-ENaC, and another
key features of this disorder is that the mineralocorticoid kindred has a similar truncation of the C-terminus
antagonist spironolactone had no effect on the sodium of g-ENaC. To date, no patients have been reported
balance, potassium secretion rate, or on the blood pres- with Liddle’s syndrome caused by similar truncations of
sure. However, the diuretic triamterene caused an in- a-ENaC.
crease in urinary sodium excretion and a reduction of An internally consistent correlation exists between the
urinary potassium excretion with an increase in serum phenotype of patients with Liddle’s syndrome and the
potassium concentration. To this day, the diuretics tri- function of mutations of ENaC when expressed in oo-
amterene and amiloride form the cornerstone of the cytes. For example, consistent with the expectation that
treatment of patients with Liddle’s syndrome. the Liddle’s mutation should increase sodium transport,
The cloning of the ENaC subunits was the final step truncation of the C-terminus of either b- or g-ENaC
that permitted the discovery that Liddle’s syndrome is produces higher sodium currents in oocytes than does
caused by genetic defects in specific regions of the b- or the full-length protein [44, 45]. The truncation of b-ENaC
g-ENaC. This discovery was facilitated by extensive prior also produces an increase in sodium current when ex-
work on the detailed mechanism of potassium secretion pressed in MDCK cells [45]. These results provide a
by the collecting duct, a clear understanding of the action solid rationale for using the oocyte expression system to
of the diuretics amiloride and triamterene, and the un- unravel at least some of the ENaC regulatory systems.
derstanding of the action of aldosterone [42]. This critical As Table 4 shows, wherever Liddle’s mutations have
mass of information, schematized in Figure 1, permitted been expressed in oocytes, they have produced an in-
crease in sodium transport. In sum, all data are consistentthe development of specific hypotheses to test the idea
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Table 4. Mutations of ENaC causing Liddle’s syndromeTable 3. Effects of complete disruption of one of the three ENaC
subunits in mice
In vitro
Subunit Mutation expression Inheritance ReferencesDisrupted Intrauterine Survival of
subunit development 2/2 mice Cause of death Reference
Frameshift and premature stop codons
b R564X .3x control Dominant [43, 44, 73]a-ENaC Normal ,36 hours Pulmonary edema [31]
b-ENaC Normal ,48 hours Hyperkalemia [36] b AV579del→582X 3.5x control Dominant [87]
b Q589X ND [43]g-ENaC Normal ,36 hours Hyperkalemia [35]
b T592fs→605X ND [43, 72]
b R594fs ND [43]
b P595fs→604X ND Dominant [88]
b R597fs→607X ND Dominant [89]
g W574X 7x control Dominant [90]with the conclusion that these mutations are, in fact,
Missense mutationsthe primary cause of Liddle’s syndrome. Figure 5 also
b P615S ND Dominant [91]
demonstrates that no known mutations in a-ENaC cause b P616L 9x control Dominant [47]
b P616S ND Dominant [49]Liddle’s syndrome. There may be a reason for this: trun-
b P616L ND Dominant [49]cation of the C-terminus of the a subunit does not in-
b Y618H 2.5x control Dominant [48]
crease the sodium current in oocytes [44, 45].
Abbreviations are: R, arginine; A, alanine; V, valine; Q, glutamine; T, threo-Liddle’s mutations could increase the sodium trans- nine; P, proline; W, tryptophan; L, lysine; S, serine; H, histidine; Y, tyrosine; X,
stop codon; del, deletion; fs, frameshift. Numbering of the amino acids is basedport rate by two general mechanisms. First, a region of
on the rat sequence. The human sequence of the b subunit contains two extrathe C-terminus could be involved in the gating properties residues upstream of the region where the point mutations exist. Thus, the actual
position of these mutations in the human sequence requires adding 2 to theof the channel. This hypothesis presumes that a portion
reported number (accession numbers L36593, X87159, X77932).of this region contains information that affects the physi-
cal properties of the channel such as its conductance or
its kinetics. The second possibility is that a region of this
C-terminus regulates the number of channels residing in to an extremely important role for this region of ENaC
in regulating its activity by surface expression.the apical membrane. It is highly likely that ENaC is
inserted into and retrieved from the apical membrane, Staub and coworkers, using the yeast two-hybrid sys-
tem, have identified a protein that binds to the PPXYbut the cellular machinery responsible for this activity
is not understood. domain of b- and g-ENaC [50]. This protein, called
Nedd4, is expressed in many cell types. Most important,A few years ago, two groups significantly advanced our
understanding of this process [45, 46]. Using somewhat it is expressed in collecting duct cells, pulmonary alveolar
cells, and distal colon epithelial cells [51]. Nedd4 containsdifferent approaches, each group showed that disruption
of the C-terminus of b- or g-ENaC resulted in more three WW domains, regions that contain two highly con-
served tryptophan residues (W) and consist of 35 to 40channels on the surface of the cell than was the case for
the wild-type channels. Firsov et al suggested that these amino acids each [52]. Nedd4 also contains a ubiquitin
ligase domain in its carboxy-terminal region. This do-mutations also might affect the gating properties of
ENaC [46], but direct evidence for such an effect has main is capable of ubiquitinating a variety of proteins,
a process involved in protein degradation. Finally, Nedd4been elusive [45]. Excellent progress has been made in
our understanding of the mechanism of aberrant surface has a C2 domain, a region involved in calcium-phospho-
lipid binding believed to be involved in endocytosis via aexpression, however.
The discovery of missense mutations involving three clathrin-AP-2 complex [53]. Other groups have provided
strong evidence that Nedd4 is involved in the surfaceamino acids in the distal portion of the C-terminus of
b-ENaC has focused attention on this region [47–49]. A expression of the ENaC complex [54–56].
A schematic interpretation of the interaction of Nedd4stretch of amino acids, PPPXY, is conserved in all three
of the ENaC subunits. This domain is similar to that with a model ENaC protein is shown in Figure 6. Binding
of the WW domain of Nedd4 to the PPXY region ofof the LDL receptor (NPXY), which is responsible for
internalization. Good evidence now indicates that this ENaC produces ubiquitination of a region in the amino
terminus of ENaC. Endocytosis might be effected viaregion is extremely important in regulating the amount
of ENaC complex residing on the cell surface. Mutation the C2 domain, which is coupled to a clathrin-mediated
process. The molecular details are unknown, but endocy-of the tyrosine residue (Y) in either the a-, b-, or g-ENaC
subunit increases the sodium current because of increased tosis of clathrin-coated vesicles depends on the protein
dynamin. Shimkets and colleagues showed that injectingsurface expression [45]. Interestingly, this surface expres-
sion phenomenon does not necessarily require the re- a dominant-negative dynamin mutant into oocytes ex-
pressing ENaC significantly increased the sodium chan-mainder of the ENaC molecule. A chimera consisting
of the C-terminus of b-ENaC with another molecule nel activity and sodium transport [57]. Taken together,
these results begin to build a new chapter in the regula-expressed on the cell surface can be equally affected by
mutating this tyrosine residue. These experiments point tion of sodium transport by the collecting duct. The dis-
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covery of the genetic defect causing Liddle’s syndrome brane ENaC were to increase the entry of sodium with-
out any safeguards (counterregulatory system), the cellthus is providing important information regarding its
pathogenesis and, in addition, insights into the normal would be at risk for a greatly increased intracellular
sodium concentration and, consequently, significantly in-regulation of ENaC surface expression.
creased cell volume. Despite wide recognition of the
Additional ways of regulating ENaC activity importance of this phenomenon, we have gained little
understanding of the molecular events leading to thisGiven the importance of ENaC for the viability of the
entire organism, it comes as no surprise that its activity counterregulation. Recently published experiments have
begun to examine this question from a new perspective.is highly regulated. The best-known regulator of its activ-
ity is, of course, aldosterone. Despite the fact that we First, there is good evidence that a G0 protein is required
for ENaC downregulation [63]. The G proteins also havehave known for more than 40 years that aldosterone
increases the activity of the epithelial sodium channel, been implicated in the upregulation of ENaC by aldoste-
rone [64]. Second, the counterregulation of ENaC activ-we still have very little specific information about the
molecular events leading to this increase. One potentially ity by intracellular sodium is defective in ENaC subunits
with the Liddle’s mutation [65]. Third, the reduction inimportant process is the regulation of transcription of
one or more of the subunits [58]. The molecular identifi- sodium transport caused by high intracellular [Na1]
might be mediated in part by Nedd4 [56]. The fact thatcation of the channel complex has been a critical step in
our understanding of how aldosterone functions. As a the Liddle’s mutations eliminate the major site of Nedd4
binding on ENaC makes this interaction of potentialresult of this discovery, investigators are making excel-
lent progress in understanding how other factors regulate pathophysiologic importance. Finally, although protein
kinase C has been implicated in this feedback processENaC activity.
Knowing the identity of ENaC has permitted the ex- [66], its precise role is still unclear.
Carboxymethylation of ENaC was recently demon-amination of how this channel is regulated. Our under-
standing of these factors is just beginning, but some are strated in vitro [67]. The potential importance of this
observation is that one mechanism for the action of aldo-now known to be involved in direct effects, as opposed
to more indirect effects, on the ENaC complex. We shall sterone has long been thought to be via methylation of
proteins [68, 69]. The fact that one of the methylatedbriefly consider those relating to the role of phosphoryla-
tion, intracellular sodium, methylation, and extracellular proteins might be ENaC itself increases the number of
potential interactions that might lead to regulation ofproteases.
It has long been recognized that the rate of sodium this complex.
We also should consider the newest mechanism wherebytransport across high resistance epithelia such as the
CCD could be altered dramatically by a number of vaso- the ENaC molecules might be regulated directly. Vallet
et al have reported that a serine protease, CAP1, whenactive substances [42]. A common mediator of many of
these agents could be kinases, such as protein kinases C coexpressed in oocytes with ENaC, increases sodium
transport [70]. The protease activity seems to be impor-and A. However, these kinases do not produce consistent
effects on the magnitude of sodium transport; their ef- tant, as an inhibitor, aprotinin, can inhibit sodium trans-
port in this system, and trypsin can activate sodium trans-fects seem to be tissue-specific [59, 60]. So there has been
considerable speculation regarding whether the ENaC port. A similar effect of aprotinin has been shown in M1
cells [71], a cell line that is derived from the mousesubunits could be phosphorylated directly. Evidence now
suggests that at least two of the ENaC subunits (b- and collecting duct. Because CAP1 is a GPI-anchored pro-
tein, it should be available to interact with other apicalg-) can be phosphorylated in vivo [61]. The consequences
of this phosphorylation are not yet clear, but some inter- membrane proteins, perhaps to alter their function in
this way. The large and complex extracellular domainesting possibilities emerge. First, serines and threonines
residing in the carboxy termini were phosphorylated. of ENaC and related proteins makes such an interaction
an attractive one to contemplate.This observation raises the intriguing possibility that
these regions might have multiple sites involved in ENaC
Do other abnormalities in ENaC cause less severe,regulation. In addition to the PPXY regions, other do-
salt-sensitive hypertension?mains might be involved. In this regard, it is interesting
to note that phosphorylated serines or threonines on One of the major reasons why we attempt to under-
stand the pathophysiology of rare genetic diseases is totarget proteins might enhance the binding of proteins
containing the WW domain, such as Nedd4 [62]. discover how similar, less flagrant but more common
disorders might be caused and treated. Hence, manyThe concentration of intracellular sodium is an impor-
tant regulatory factor in transepithelial sodium transport. investigators in the field of hypertension are intrigued
by the possibility that some people with hypertensionThe physiologic role of this feedback mechanism is main-
tenance of intracellular homeostasis. If the apical mem- have genetic differences in ENaC subunits that produce
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more subtle changes in the function of the channel com- phenotype (such as hypokalemia). Genetic diversity can
be controlled or eliminated in rodents bred for specificplex, not produce overt hypokalemia, but still contribute
to salt-sensitive hypertension. A good rationale exists for traits, such as hypertension. Many years ago Rapp re-
fined the Dahl salt-sensitive (S) and salt-resistant (R)us to suspect that an intrinsic defect in ENaC produces
increased sodium absorption without hypokalemia. Even strains of rat and inbred them [79]. These animals now
represent a valuable resource for investigating specificsome members of a family with the abnormal Liddle’s
ENaC gene express a mild phenotype [72]. Thus, it is genes that contribute to hypertension. Other inbred
strains such as the spontaneously hypertensive rat arereasonable to presume that mutations producing a milder
functional disorder might produce hypertension in the similarly valuable, as different genes can interact in vari-
ous ways to produce hypertension.setting of an abundant sodium intake without produc-
ing hypokalemia and metabolic alkalosis. Such mild phe- Do Dahl S rats have an abnormality in collecting duct
sodium transport? To address this question, we havenotypes even might have provided a selective survival
advantage under circumstances in which dietary sodium refined the method of measuring sodium transport in
primary cultures of inner medullary collecting duct cells.was meager.
Given this possibility, investigators have begun to ex- These cells, when grown as monolayers on filters, have
sodium transport that is stimulated by steroids and inhib-amine populations of salt-sensitive hypertensive patients
to determine whether indeed such mutations exist in any ited by amiloride [80]. The pathway for sodium entry in
these cells is ENaC [81]. When we measured sodiumof the ENaC subunits. Not surprisingly, the search has
been concentrated in the carboxy termini of b- and transport by cultured inner medullary collecting duct
cells from Dahl S and R rats, we found that S rat mono-g-ENaC, because the defects that produce Liddle’s syn-
drome reside in those regions (Fig. 5). To date, several layers transported about twice as much sodium as did R
rat monolayers [82]. The reason for this difference isreports have documented polymorphisms in b- and
g-ENaC [73, 74]. However, these polymorphisms do not that S monolayers permit more sodium entry than do R
segregate with hypertension in family members, even monolayers [83]. These results point to the possibility
though many of them were found more commonly in that the ENaC genes or factors responsible for their
individuals of African origin. When these variants have regulation differ in these two strains. To date, no con-
been expressed in oocytes, a significant functional differ- vincing data have implicated genetic abnormalities in
ence has not been noted [74]. ENaC subunits in any rat model of hypertension [84, 85].
The search has uncovered one polymorphism that However, given the progress in unraveling the factors
might play a role in salt-sensitive hypertension. Su et al involved in regulating ENaC, progress in understanding
reported that a single amino acid substitution in the b salt-sensitive hypertension in the rat is likely as well.
subunit (bT594M) was found in 6% of African-Ameri- In summary, the discovery of the ENaC proteins has
can subjects, but this substitution was not found in their opened the door to discovering major secrets to the func-
Caucasoid population [75]. Furthermore, this mutation tion of the collecting duct and the regulation of sodium
was believed to render amiloride-sensitive sodium cur- balance. It is easy to predict that this family of proteins
rents in lymphocytes unresponsive to phorbol esters and will continue to amaze us as we discover more family
more sensitive to the stimulatory effects of cAMP ana- members and explore their biologic diversity. It is safe
logues [75, 76]. The interpretation of these data has been to assume that we will continue to learn the molecular
difficult. One question relates to the significance of ami- details of how this complex functions and how the mole-
loride-sensitive currents in lymphocytes, as the charac- cules involved in its regulation contribute to disease.
teristics of these currents are quite different from those
reported in cells expressing ENaC. Lymphocytes might
QUESTIONS AND ANSWERShave a different assembly of ENaC or a different sodium
Dr. Nicolaos E. Madias (Chief, Division of Nephrol-channel [77]. The possible contribution of this mutation
ogy, New England Medical Center, Boston, Massachu-to hypertension has been evaluated in hypertensive Afri-
setts): Thank you for a fine presentation. I find it fascinat-can subjects residing in London. The bT594M mutation
ing that by far the largest portion of the ENaC proteinoccurred more frequently than in normotensive African
is extracellular, being bathed by urine and fecal contentssubjects [78]. Whether this mutation actually plays a
in the case of kidney and colon, respectively. It is tempt-role in the pathogenesis of salt-sensitive hypertension in
ing to consider that it is there for a cause. Are there anyhumans will require further investigation.
data to support the notion that this segment might harbor
Salt-sensitive hypertension in rats a sodium sensor or a regulatory domain that interacts
with its environment?The genetic diversity of humans makes unraveling the
Dr. Stokes: Unfortunately, there is no evidence thatarray of genes that predispose to hypertension a formida-
ble undertaking when there is no readily identifiable the extracellular domain of ENaC acts as a sodium recep-
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tor. Nonetheless, endocrinologists who have looked at answer it in two parts. The first part is that aldosterone
in some, but not in all, tissues increases sodium transportthis channel say that it appears just like a receptor. Many
people have been struck, as you have been, by the fact in a biphasic fashion. The biphasic response is character-
ized as an early response and a late response. The earlythat there is an enormous amount of complexity in the
extracellular domain. It is attractive from the physiologic response can be seen within an hour or two. Six to 24
hours later, there is a greater increase in sodium trans-perspective to postulate that something in the urine
might be able to regulate the activity of that sodium port. The classic way of thinking about this is that two
types of transcriptional responses are occurring, al-channel, perhaps something produced by an upstream
segment of the nephron. We’ve looked hard and not though some evidence suggests that aldosterone pro-
duces non-transcriptional responses too [92].been able to uncover anything that we think behaves in
that fashion. I would speculate that we will ultimately As your question implies, good evidence suggests that
aldosterone increases the magnitude of sodium transportdiscover how this large extracellular domain interacts
with its environment. An important recent discovery is by increasing the entry of sodium through ENaC and by
increasing the activity of the Na1/K1 ATPase. Aldoste-that the serine protease CAP1 might alter the extracellu-
lar domain and thus alter the gating of the channel [70]. I rone’s effect on the latter is modest and poorly under-
stood. Its effect on ENaC is still under intense investiga-expect that this interaction with the extracellular domain
will be the subject of considerable attention over the tion, but important clues have recently emerged. One of
the clearest and best-described actions of aldosterone isnext few years.
Other members of this family, which may be expressed that it increases the transcription of one or more of the
ENaC subunits. In the kidney and lung, steroids increaseas single proteins, are not necessarily devoted only to
sodium transport as ENaC is. If they are mechanosen- the mRNA levels of a-EnaC, while in the colon, steroids
increase the levels of b- and g-EnaC mRNA [37]. It issors, the extracellular domain can respond to perturba-
tions in the physical environment. Thus, the extracellular likely that this increase largely reflects an increase in the
rate of transcription [58]. However, why the response indomain can transmit a signal causing opening of the
channel and allowing sodium, potassium, or calcium into the colon differs from the response in the kidney and in
the lung is unknown.the cell. In that sense, the protein could act as a receptor
for an environmental stimulus. I would not be surprised Another mystery involves the fact that in the kidney
the increase in the mRNA level of a-ENaC does notif ENaC functioned similarly.
Dr. John T. Harrington (Dean, Tufts University necessarily correspond with the increase in sodium ab-
sorption. Rats fed a low-NaCl diet increase the rate ofSchool of Medicine, Boston): I’m also struck by the size of
this channel. Does the extracellular loop actively direct sodium transport in the cortical collecting duct, but
ENaC mRNA levels are unchanged [37]. In the innersodium movement down to the membrane, or does the
loop simply trap sodium in a passive way, the sodium, medulla, the correlation between the magnitude of so-
dium transport and a-EnaC mRNA is much tighter [37,if you will, then floating down to the membrane?
Dr. Stokes: There’s not enough information to answer 80, 81].
There has been quite a bit of effort directed at tryingthat question precisely. The cartoons that people like to
draw would have that large extracellular domain act like to discover other aldosterone-induced proteins. Recently
three proteins have been described that are induced bya funnel into which sodium can be directed. At the base
of that funnel, the area proximal to the second mem- aldosterone and are reasonable candidates for regulation
of the ENaC and/or Na1/K1 ATPase activity.brane-spanning domain might act as a specific site for
sodium binding and also amiloride binding. It is that site The first protein, CHIF (channel-inducing factor), was
cloned from the rat colon and is regulated by potassiumthat probably directs the sodium into the channel. The
binding of sodium does not require ATP. Everything we balance and aldosterone [93]. Unfortunately, we don’t
know how that protein might interact with ENaC. Theknow about the ENaC suggests that the magnitude of
sodium transport is driven by the electrochemical gradi- second protein is a RAS family member: Kras 2. It is
induced by aldosterone in A6 cells, an amphibian cellent. It does not need any extra energy to effect sodium
transfer from one side to the other. This is a passive line [94]. Its role in the regulation of ENaC is not clear.
The third protein, sgk (serum and glucocorticoid-regu-process, but it is regulated by the binding sites that line
the pore. lated kinase) [95], was discovered a few months ago
to be an aldosterone-induced protein. It was originallyDr. Madias: Can you summarize for us what is known
about the mechanism of regulation by aldosterone of cloned from mammary epithelial cells exposed to serum
and glucocorticoids. It is called a kinase because it looksthe activities of the apical sodium and potassium chan-
nels and the basolateral sodium pump? Is there a well- like a kinase. To date, there is no direct proof that it
actually is a kinase, and its substrate is unknown. Never-defined temporal sequence in these regulatory functions?
Dr. Stokes: That’s a complicated question and I’ll theless, this protein is induced by steroids in epithelial
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cells, and when co-injected into Xenopus oocytes with With regard to the question of the “chloride shunt”
hypothesis, we will have to wait for the identification ofENaC, sodium transport is increased. Sgk is a promising
candidate molecule for mediating the action of aldoste- the affected genes. Progress has been made in this area,
as regions of chromosomes 1 and 17 have been impli-rone.
Dr. Harrington: Is there exact structural similarity cated in a group of families with this syndrome [96].
At present, discussions regarding an enlarged “chloridebetween the renal epithelial sodium channel and the
sodium channel in other cells? Second, in patients with shunt” must be considered speculative.
Dr. Madias: Regarding the third type of PHA, wouldLiddle’s syndrome, are the functional defects within re-
nal epithelial cells expressed in non-renal tissues? you reflect on the potential basis of aldosterone resis-
tance in these patients?Dr. Stokes: The primary sequence of a-, b-, and
g-ENaC subunits in kidney, colon, and lung is identical. Dr. Stokes: Type-III PHA is more common in clinical
medicine than is type-I or type-II. The syndrome is aWe are not yet sure about the stoichiometry of the chan-
nel. One view is that the stoichiometry is 2a:1b:1g [13, consequence of one or more factors that render the col-
lecting duct insensitive to aldosterone. One possibility14]. Another view is that the stoichiometry is 3a:3b:3g
[15, 16]. One can experimentally manipulate the oocyte that is attractive to us based on some work in our labora-
tory is that disorders such as obstruction, medullary cys-expression system so that more of one kind of subunit
is expressed than the others. Depending on this relation- tic disease, or inflammation produce increasing amounts
of TGF-b. We know from our previous studies thatship, one can get different characteristics of the sodium
channel [17]. Nobody will be surprised if the function of TGF-b renders the collecting duct insensitive to aldoster-
one [97]. I would not be surprised if patients with thesethe sodium channel in lung, sweat gland, salivary gland,
or colon might be slightly different than in the collecting disorders have increased production of a factor such as
TGF-b that would inactivate the aldosterone-responseduct of the kidney, depending in part on how these sub-
units are assembled. We have recently discovered a strik- system.
Dr. Harrington: I’m still having trouble with theing example of heterogeneity of ENaC subunits in uro-
epithelial cells. There are large amounts of b- and g-ENaC type-I PHA story. While the patients have terrible prob-
lems in the first years of life, they subsequently do well.mRNA from the renal pelvis to the urinary bladder, but
there is almost no trace of a-ENaC [20]. The urinary I don’t understand what changes occur at ages three to
six years and what regulates the changes that result inbladder epithelium is not known to absorb a lot of so-
dium. We are not sure how these subunits function, or the patient becoming healthy.
Dr. Stokes: I don’t understand that either. I think thatwhether they form a channel. We think that they might
play a role in mechanosensation and might participate patients with autosomal-dominant type-I PHA (like our
Patient 1) are trying to tell us something. Certainly, itin sensing the amount of distention in the ureters, pelvis,
and bladder. has something to do with the maturation of the human
collecting duct, the human mineralocorticoid receptor,Dr. Madias: I have a question on each of the three
types of pseudohypoaldosteronism. Regarding the au- and the apparatus responsible for responding to aldos-
terone.tosomal-recessive type-I PHA, are there any functional
consequences of the heterozygous state under conditions Dr. Harrington: Why did Grant Liddle’s patient go
into renal failure 29 years later? Did it have anything toof stress, such as low-sodium diet?
Dr. Stokes: I’m not aware of any published studies do with Liddle’s syndrome, or did she develop another
renal disease?in this regard, but the hypothesis that people are studying
is that these patients, when they are put under stress, Dr. Stokes: This patient was reported twice, the first
time by Liddle and coworkers [40] and the second timedemonstrate a modest but measurable defect in their
ability to retain sodium or excrete potassium. They also by Botero-Valez et al [41]. The latter report suggests
that she developed renal failure from hypertension. Nocan have elevated baseline levels of aldosterone and
renin, so they might be chronically volume contracted. other renal disease was evident at the time of trans-
plantation. The success of the blood pressure controlDr. Madias: Concerning the second type, I agree that
the designation of PHA is a misnomer. Do patients with following successful transplantation underscores the im-
portance of the kidney in the pathophysiology of hyper-this syndrome respond to mineralocorticoids? Is there
any recent evidence to support or refute the “chloride tension in Liddle’s syndrome.
Dr. Madias: Obviously, a number of sodium-trans-shunt” hypothesis as the cause of the syndrome?
Dr. Stokes: The answer is complicated by the fact porting proteins could contribute to the pathogenesis of
hypertension. Could you summarize for us the availablethat type-II PHA is found in a heterogeneous group
of patients. The best-studied group was presented by knowledge in experimental models of hypertension?
Also, what about abnormalities in these molecules as aGordon [2]. These patients do respond to mineralocorti-
coid hormones. contributor to salt resistance?
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Dr. Stokes: Inbred rat strains are valuable models for a-ENaC is defective. The physiologic significance of
d-ENaC is unknown.sorting out the molecules responsible for the develop-
ment of hypertension. Many laboratories are using ge-
netic approaches to discover precisely which genes pro- ACKNOWLEDGMENTS
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